User profiles for Daniel H. Sterman

Daniel Sterman

Professor of Medicine and Cardiothoracic Surgery, NYU School of Medicine
Verified email at nyumc.org
Cited by 12543

Tumors of the mediastinum

BV Duwe, DH Sterman, AI Musani - Chest, 2005 - Elsevier
Tumors of the mediastinum represent a wide diversity of disease states. The location and
composition of a mass is critical to narrowing the differential diagnosis. The most common …

[HTML][HTML] A phase I trial of repeated intrapleural adenoviral-mediated interferon-β gene transfer for mesothelioma and metastatic pleural effusions

DH Sterman, A Recio, AR Haas, A Vachani, SI Katz… - Molecular Therapy, 2010 - cell.com
We previously showed that a single intrapleural dose of an adenoviral vector expressing
interferon-β (Ad.IFN-β) in patients with malignant pleural mesothelioma (MPM) or malignant …

Interventional pulmonology

LM Seijo, DH Sterman - New England Journal of Medicine, 2001 - Mass Medical Soc
Interventional pulmonology is a new field within pulmonary medicine focused on the use of
advanced bronchoscopic and pleuroscopic techniques for the treatment of a spectrum of …

Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype

…, C Ubeda, A Artacho, WN Rom, DH Sterman… - Nature …, 2016 - nature.com
Microaspiration is a common phenomenon in healthy subjects, but its frequency is
increased in chronic inflammatory airway diseases, and its role in inflammatory and immune …

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in …

DH Sterman, J Treat, LA Litzky, KM Amin… - Human gene …, 1998 - liebertpub.com
Malignant pleural mesothelioma is a fatal neoplasm that is unresponsive to standard modalities
of cancer therapy. We conducted a phase I dose-escalation clinical trial of adenoviral (Ad…

A phase I clinical trial of single-dose intrapleural IFN-β gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor …

DH Sterman, A Recio, RG Carroll, CT Gillespie… - Clinical Cancer …, 2007 - AACR
Purpose: This phase 1 dose escalation study evaluated the safety and feasibility of single-dose
intrapleural IFN-β gene transfer using an adenoviral vector (Ad.IFN-β) in patients with …

Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma

…, K Sumino, M Kraft, G Cox, DH Sterman… - Journal of allergy and …, 2013 - Elsevier
Background Bronchial thermoplasty (BT) has previously been shown to improve asthma
control out to 2 years in patients with severe persistent asthma. Objective We sought to assess …

Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline

…, NA Maskell, NM Rahman, DH Sterman… - American journal of …, 2018 - atsjournals.org
Background: This Guideline, a collaborative effort from the American Thoracic Society,
Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence-…

A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety …

…, J Hampl, S Mathur, J Nemunaitis, DH Sterman… - Clinical cancer …, 2012 - AACR
Purpose: Listeria monocytogenes (Lm)-based vaccines stimulate both innate and adaptive
immunity. ANZ-100 is a live-attenuated Lm strain (Lm ΔactA/ΔinlB). Uptake by phagocytes in …

Lower airway dysbiosis affects lung cancer progression

…, WN Rom, DH Sterman, HI Pass, JC Clemente, H Li… - Cancer discovery, 2021 - AACR
Multiple lines of investigation have shown that the gut microbiota affects host immune
response to immunotherapy in cancer. Here, we support that the local airway microbiota …